Quarterly report [Sections 13 or 15(d)]

SEGMENT INFORMATION (Tables)

v3.25.1
SEGMENT INFORMATION (Tables)
3 Months Ended
Mar. 31, 2025
SEGMENT INFORMATION  
Schedule of segment information

​

​

​

​

​

​

​

​

​

​

Three Months Ended March 31, 

​

​

2025

​

2024

​

​

(in thousands)

Total Revenues

​

$

53,333

​

$

29,534

Less:

​

​

​

​

​

​

Employee related expenses

​

​

19,538

​

​

19,367

Commercial related expenses

​

​

5,339

​

​

5,109

Outside clinical trial related expenses

​

​

4,371

​

​

2,512

Cost of product sales

​

​

4,409

​

​

2,025

Consultants and third-party services

​

​

3,409

​

​

4,343

Other segment items

​

​

3,494

​

​

3,144

Interest expense, net

​

​

1,262

​

​

1,281

Provision for income taxes

​

​

65

​

​

—

Segment income (loss)

​

$

11,446

​

$

(8,247)